PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2021

Feb 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-02-12

Reporting Person: Zago Wagner M. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-18	Ordinary Shares, par value $0.01 per share	M	7540	$6.41	Acquired	7540	Direct
2021-02-18	Ordinary Shares, par value $0.01 per share	S	7540	$25.50	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-18	Stock Option (Right to Buy)	$6.41	M	7540	Disposed	2023-01-29	Ordinary Shares (7540)	Direct

Footnotes

F1: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: The shares subject to the option were fully vested as of the date of the exercise.